Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Multiple sclerosis

Recent news which mentions Multiple sclerosis

Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
Tickers NEWS SNY
Tags Health Care multiple sclerosis Market News
From Benzinga
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Tickers HUGE
Tags Cannabis Benzinga General
From Benzinga
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags Autism Alzheimer's disease Cannabis
From Benzinga
A New Music Video "Axolotl Dance" Combines Education and Entertainment
Tags Nashua Axolotl Movies
From PRLog
Jazz Pharmaceuticals Analysis Reveals THC And CBD Therapy Alleviates MS Spasticity
Tickers JAZZ
Tags medical marijuana JAZZ spasticity
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
Tickers HUGE
Tags Psychedelic/Assisted Therapies Markets HUGE
From Benzinga
Novel Compound Begins Clinical Testing For Potential Treatment Of Multiple Sclerosis
Tickers HUGE
Tags News Management Markets
From Benzinga
How to help loved ones with disabilities during the holidays, from a TV host whose family struggled with aunt's MS diagnosis
Tags Make It Holidays Family gatherings
From CNBC.com News
Michelle Obama's new book puts a spotlight on multiple sclerosis and her father's late diagnosis: Here are 5 early signs of the disease
Tags Health Tips and Wellness Advice Multiple sclerosis Make It / Life
From CNBC.com News
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
Tickers KTTA
Tags Penny Stocks News Monkeypox
From Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
Tickers BIIB MS
Tags multiple sclerosis Tecfidera Michael Bawduniak
From Benzinga
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know For Now
Tickers CBD DEA
Tags Markets Benzinga Market News
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
Tickers NVS
Tags Briefs multiple sclerosis Phase 3 Trial
From Benzinga
Living Out Our Commitment for Patients: MS Awareness Month 2022
Tickers BMY
Tags Multiple Sclerosis Bristol Myers Squibb MS Awareness Month
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Michigan's JARS Cannabis And Others Join Forces To Raise Awareness During MS Awareness Month
Tickers RSO
Tags RSO Benzinga General
From Benzinga
EXCLUSIVE: Pasithea Therapeutics Starts New Multiple Sclerosis Vaccine Development Program
Tickers KTTA
Tags Biotech KTTA Penny Stocks
From Benzinga
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
Tickers BIIB VTRS
Tags Biotech BIIB Legal
From Benzinga
Europe OKs Biogen's Vumerity For Multiple Sclerosis
Tickers BIIB
Tags Briefs Health Care FDA
From Benzinga
5 Things You Might Not Know About Apple CEO Tim Cook
Tickers AAPL IBM TECH
Tags Movers & Shakers Education General
From Benzinga
Why Did AstraZeneca's Alexion Stop Amyotrophic Lateral Sclerosis Trial?
Tickers AZN AZNCF
Tags AZN General Benzinga
From Benzinga
Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis
Tickers CLNN
Tags CLNN Biotech News
From Benzinga
MedRhythms raises $25M to get patients back in tune after a stroke
Tickers TC
Tags Portland Funding Parkinson's Disease
From TechCrunch
Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate
Tickers BIIB
Tags Biotech BIIB Contracts
From Benzinga
Eli Lilly, Verge Genomics Ink $720M Pact For Amyotrophic Lateral Sclerosis Therapies
Tickers LLY
Tags Biotech LLY News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.